Cendakimab (RPC4046) is a humanized monoclonal antibody targeting IL-13. It selectively targets the IL-13 receptor (IL13R-alpha1 and IL13R-alpha2), used in research on atopic dermatitis.
Purity:
>95%
CAS Number:
[2151032-62-9]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted